Trip up north to learn with @NIHRresearch https://t.co/IuKY766M8E about maternity workforce, general medical training evaluation, neighbourhood working and more, on a campus built on the site of an old brewery
📢One week left to apply for @NRAPaudit healthcare improvement clinical fellow. @ARNS_UK @BTSrespiratory @PRaccreditation
For further information and how to apply visit: https://t.co/RMNB6qE5J7
Missed our recent #AATD live event from Amsterdam? Watch the onDemand video to get insights on proactive screening, cross-specialty collaboration, and the current treatment landscape.
#PeerVoice#meded#AATD#pulmonology#hepatology
https://t.co/VPSE5Smbt5
The A1F team kicked off #Alpha1Awareness Month and the A1F Virtual Walk 2025 together at our Coral Gables office! The energy is high and we are ready for a month of awareness, advocacy, and community. Join us and be part of the movement: https://t.co/K6ZnxIx5nV
Here’s a reminder of the #WMPAMatMed programme happening at UHCW next month
Features talks on chest pain, headache and endocrine emergencies, plus research abstracts, case reports and posters in adult general internal medicine
Register here: https://t.co/cebyEdKryI
Great day with @NIHRPSRCs discussing safety equity. Loved the live graphics summarising talks (@PSRC_Midlands highlights 👇🏻) and the summary of maternal care pathway through an equity lens
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease
PM2.5 and its constituents are associated with differential DNA methylation in the blood of patients with fibrotic ILD
@atscommunity
🔗 https://t.co/08LyOFDFSi
Great talk on microplastics & lung health #ERSCongress2025 Key messages - more ingestion from air than gut, thus most deposition in the lung. Links to #COPD & ILD. The type of plastic matters
Methods to prevent respiratory disease and it's impacts, from #airquality interventions, case finding, lifestyle & more - summarised by @WHO in this report focussed on Europe #ERSCongress2025 https://t.co/rFqXmTBMnj
Join us for our next SafetyNet webinar: Understanding and measuring emergency doctors’ tolerance of clinical uncertainty on Wednesday 12 November
🔗Book your place: https://t.co/7Sg8pnFZp1...
@drwilliamlea@NIHRPSRCs#emergencymedicine
ALIENTO study of Astegolimab, targeting IL33 in #COPD. Marginal effect on AECOPD, direction same as (negative) ARNASA study. Maybe too broad/late population? #ERSCongress2025
Started #ERSCongress2025 with an excellent NTM session. Take homes: many new routes to Rx, CFTR & GM-CSF clinical data promising. BACES score aids prognostication
"We" need clinical trials & translational research, but the urgent gap is in health services & implementation science. We know much of what works; the challenge is delivering it equitably, affordably, and sustainably. Research must meet reality.
Treatable traits!
New! We compare inflammation, microbiome, rheology and mucins in asthma, COPD, bronchiectasis, CF and controls. Huge overlap in biology but clear neutrophilic and T2 endotypes in all diseases!
Endotypes>disease labels
@accpchest
https://t.co/61KzACwcGt
Original research shows that preserved ratio impaired spirometry (PRISm) was associated with transition into airway obstruction corresponding to #COPD within one decade.
Read more in the August issue of the journal CHEST®: https://t.co/gcDSUxZShA
#MedEd#JournalCHEST
🚑 Maximising Ambulance Referrals into virtual wards via Single Point of Access (SPOA).
Dr Shelagh O’Riordan will be in conversation with ambulance & A&E colleagues exploring streamlining ambulance referrals into virtual care.
📅 Register: https://t.co/ql9SwTZaED
@jupiterhouse1